About ReGenTree
The company was founded with the aim of becoming a global leader in the pharmaceutical industry for ophthalmic disorders.
Learn MorePipeline
ReGenTree is focusing on eye products for dry eye syndrome and for neurotrophic keratopathy with the naturally occurring regenerative protein, Thymosin β4 (Tβ4).
Learn MoreNews & PR
- 2021.05.14 ReGenTree Announces Additional Results...
- 2021.02.24 RegeneRx JV Locks Clinical Trial Datab...
- 2020.11.09 Last Patient, Last Visit Completed in ...